Señales en vivo de 002349.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 03:04):

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China...

Stats
Volumen de hoy	10.40M
Volumen promedio	14.60M
Capitalización de mercado	6.38B
EPS	CNY0.0500 ( 2023-09-30 )
Próxima fecha de ganancias	( CNY0 ) 2024-05-17
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	26.23
ATR14	CNY0.0100 (0.13%)

Volumen Correlación

Largo: 0.15 (neutral)

Corto: 0.33 (neutral)

Signal:(54.459) Neutral

Jinghua Pharmaceutical Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Jinghua Pharmaceutical Correlación - Moneda/Commodity

0.36
( neutral )

0.44
( neutral )

0.00
( neutral )

-0.73
( moderate negative )

-0.38
( neutral )

Jinghua Pharmaceutical Finanzas

Annual	2023
Ingresos:	CNY1.49B
Beneficio Bruto:	CNY692.96M (46.49 %)
EPS:	CNY0.300

FY	2023
Ingresos:	CNY1.49B
Beneficio Bruto:	CNY692.96M (46.49 %)
EPS:	CNY0.300

FY	2022
Ingresos:	CNY1.57B
Beneficio Bruto:	CNY735.15M (46.73 %)
EPS:	CNY0.260

FY	2021
Ingresos:	CNY1.36B
Beneficio Bruto:	CNY632.18M (46.56 %)
EPS:	CNY0.200

Financial Reports:

No articles found.

Jinghua Pharmaceutical

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. Jinghua Pharmaceutical Group Co., Ltd. was founded in 1957 and is based in Nantong, China.